These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 1718700)
21. Review of calcium antagonist trials in acute myocardial infarction. Roberts R Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III41-7. PubMed ID: 2691141 [TBL] [Abstract][Full Text] [Related]
22. Effect of intravenous nifedipine on hemodynamics and left ventricular function in acute myocardial infarction. Blanke H; Leschke M; Motz W; Strauer BE J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S153-60. PubMed ID: 2485022 [TBL] [Abstract][Full Text] [Related]
23. Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel. A comparison between 1981-1983 and 1992-1994. For the SPRINT and the Israeli Thrombolytic Survey Groups. Gottlieb S; Goldbourt U; Boyko V; Harpaz D; Mandelzweig L; Khoury Z; Stern S; Behar S Eur Heart J; 2000 Feb; 21(4):284-95. PubMed ID: 10653676 [TBL] [Abstract][Full Text] [Related]
24. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction. Beckwith C; Munger MA Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800 [TBL] [Abstract][Full Text] [Related]
25. Nifedipine after acute myocardial infarction--sola dosis facit venenum: only the dose determines the harm. Messerli FH Cardiovasc Drugs Ther; 1998 May; 12(2):149-50. PubMed ID: 9652872 [No Abstract] [Full Text] [Related]
26. Nifedipine therapy for coronary vasospasm. Stone PH; Antman EM; Muller JE Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():137-42. PubMed ID: 6407436 [TBL] [Abstract][Full Text] [Related]
27. Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks. Liu L; Chin Med J (Engl); 2001 Feb; 114(2):115-8. PubMed ID: 11780187 [TBL] [Abstract][Full Text] [Related]
28. Calcium antagonists during and after myocardial infarction. Sleight P Drugs; 1996 Feb; 51(2):216-25. PubMed ID: 8808164 [TBL] [Abstract][Full Text] [Related]
29. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction. Poulsen SH Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125 [TBL] [Abstract][Full Text] [Related]
30. Secondary prevention of death and reinfarction with verapamil after an acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction. J Hum Hypertens; 1990 Dec; 4 Suppl 5():19-25. PubMed ID: 2090834 [TBL] [Abstract][Full Text] [Related]
31. Calcium antagonists for secondary prevention of myocardial infarction: is there a need to shift from short-acting to long-acting types? Taniwa T; Miyataka M; Kimura A; Taniguchi M; Hirano Y; Hayashi T; Ishikawa K Circ J; 2005 Nov; 69(11):1308-14. PubMed ID: 16247203 [TBL] [Abstract][Full Text] [Related]
32. Nifedipine and acute myocardial infarction. Roberts R; Jaffe AS; Henry PD; Sobel BE Herz; 1981 Apr; 6(2):90-7. PubMed ID: 7227967 [TBL] [Abstract][Full Text] [Related]
33. [Hemodynamic effect of intravenous diltiazem and nifedipine in acute myocardial infarct. A randomized study]. Drexler H; Hümmler S; Zeiher A; Kasper W; Meinertz T; Just H Dtsch Med Wochenschr; 1987 Sep; 112(37):1412-7. PubMed ID: 3304930 [TBL] [Abstract][Full Text] [Related]
34. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. Yusuf S; Mehta SR; Chrolavicius S; Afzal R; Pogue J; Granger CB; Budaj A; Peters RJ; Bassand JP; Wallentin L; Joyner C; Fox KA; JAMA; 2006 Apr; 295(13):1519-30. PubMed ID: 16537725 [TBL] [Abstract][Full Text] [Related]
35. Nifedipine does not improve survival in AMI patients without heart failure. The SPRINT Study Group. Mandelzweig L; Goldbourt U; Reicher-Reiss H; Behar S; Kaplinsky E Cardiovasc Drugs Ther; 1993 Feb; 7(1):117-8. PubMed ID: 8485066 [No Abstract] [Full Text] [Related]
36. Clinical predictors of reinfarction among men and women after a first myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Kornowski R; Goldbourt U; Boyko V; Behar S Cardiology; 1995; 86(2):163-8. PubMed ID: 7728808 [TBL] [Abstract][Full Text] [Related]
37. Treatment with verapamil during and after an acute myocardial infarction: a review based on the Danish Verapamil Infarction Trials I and II. The Danish Study Group on Verapamil in Myocardial Infarction. Hansen JF J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S20-5. PubMed ID: 1725912 [TBL] [Abstract][Full Text] [Related]
38. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group. Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317 [TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of infarction location in patients with recurrent myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israel Nifedipine Trial. Kornowski R; Goldbourt U; Reicher-Reiss H; Reisin L; Haim M; Moshkovitz Y; Caspi A; Behar S Cardiology; 1997; 88(5):441-5. PubMed ID: 9286506 [TBL] [Abstract][Full Text] [Related]
40. Intravenous nifedipine for prevention of myocardial ischaemia after coronary revascularization. Dupuis JY; Nathan HJ; Laganière S Can J Anaesth; 1992 Dec; 39(10):1012-22. PubMed ID: 1464126 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]